(2R)-methyl 2-(2-chlorophenyl)-2-(2-oxo-7,7a-dihydrothieno[3,2-c]pyridin-5(2H,4H,6H)-yl)acetate
95%
- Product Code: 229053
CAS:
1360923-54-1
| Molecular Weight: | 337.82 g./mol | Molecular Formula: | C₁₆H₁₆ClNO₃S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
Used in pharmaceutical synthesis as an intermediate for developing potent anticoagulant agents. Shows high affinity in inhibiting specific serine proteases involved in blood coagulation pathways. Its structure enables selective binding, making it valuable in creating novel oral anticoagulants with improved safety profiles. Also investigated for use in treatments requiring controlled thrombin inhibition, such as in prevention of deep vein thrombosis and stroke in atrial fibrillation patients.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 10mg | 10-20 days | ฿80,000.00 |
+
-
|
(2R)-methyl 2-(2-chlorophenyl)-2-(2-oxo-7,7a-dihydrothieno[3,2-c]pyridin-5(2H,4H,6H)-yl)acetate
Used in pharmaceutical synthesis as an intermediate for developing potent anticoagulant agents. Shows high affinity in inhibiting specific serine proteases involved in blood coagulation pathways. Its structure enables selective binding, making it valuable in creating novel oral anticoagulants with improved safety profiles. Also investigated for use in treatments requiring controlled thrombin inhibition, such as in prevention of deep vein thrombosis and stroke in atrial fibrillation patients.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :